Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Urologix (DE:UX1)
BERLIN:UX1
Urologix (UX1) Stock Price & Analysis
0 Followers
UX1 Stock Chart & Stats
Day’s Range€0.81 - €0.81
52-Week Range― - ―
Previous Close€0.81
Volume0.00
Average Volume (3M)N/A
Market Cap
$2.07K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.18% Other Institutional Investors
99.82% Public Companies and
Individual Investors
UX1 FAQ
What was Urologix’s price range in the past 12 months?
Currently, no data Available
What is Urologix’s market cap?
Currently, no data Available
When is Urologix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Urologix’s earnings last quarter?
Currently, no data Available
Is Urologix overvalued?
According to Wall Street analysts Urologix’s price is currently Overvalued.
Does Urologix pay dividends?
Urologix does not currently pay dividends.
What is Urologix’s EPS estimate?
Urologix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Urologix have?
Currently, no data Available
What happened to Urologix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Urologix?
Currently, no hedge funds are holding shares in DE:UX1
---
Company Description
Urologix
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.
---
Technical Analysis
---